AROMICS among the 8 companies selected by MIT IDEA2 program

Imagen Noticia

MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the eight teams admitted to IDEA2 2024. The seven-month program provides intensive innovation method training, collaborative project development, team-specific mentoring, and expertise to help projects move from novel ideas toward real-world application. 

Proposals for IDEA2 were invited from anywhere in the world, and selected teams come from Sweden, Spain, Chile, Argentina, Poland, and the United States. IDEA2 program contributors for the 2024 edition include the MIT Institute for Medical Engineering and Science (IMES), the MIT Deshpande Center, the Medicine Innovation Program at Massachusetts General Hospital, the US Department of Veterans Affairs, Boston Landing, and MIT Hacking Medicine.